Belfast Based Startup to Develop a Mobile App, Harnessing Artificial Intelligence, to Provide Communication Tool for Voice-Impaired Patients

LiopaLiopa, a spin out of the Centre for Secure Information Technologies (CSIT) at Queen's University Belfast (QUB) has announced that it is to deliver a prototype patient/carer communications aid. It will be used by tracheostomy patients in critical care environments.

Working along with Lancashire Teaching Hospitals NHS Foundation Trust and Queen's University Belfast, Liopa will develop SRAVI (Speech Recognition App for the Voice Impaired). Compared to the limited alternatives available, SRAVI will provide an easy-to-use, accurate and cost effective method for communication between these patients, their family members and healthcare staff. SRAVI will integrate with LipRead, Liopa's artificial intelligence engine for Visual Speech Recognition.

This initial project will focus at a select group of patients with tracheostomies (approximately 10,000 tracheostomies are performed annually in the UK) who currently struggle to vocalise but can move their lips normally. Whilst the initial prototype will support a limited vocabulary in English, the application can be further developed to support larger vocabularies across multiple languages.

Clinical Professor Danny McAuley at QUB's Wellcome-Wolfson Institute for Experimental Medicine and Consultant at the Belfast Trust commented, "The inability to communicate during an ICU stay is a major source of morbidity for patients, family and staff. A patient's non-verbal attempts to communicate are often difficult to understand which can be frustrating for patients and carers. This novel approach may allow better communication between the patient, staff and family from an early stage."

"This is an innovative application of our proven AI-based Visual Speech Recognition (VSR) system LipRead. LipRead analyses and translates lip movements into recognisable words. The technology allows the translation of lip movement to text using a mobile app on a mobile device which will need very little training and is inexpensive," said Liam McQuillan, Co-founder and CEO, Liopa. He continued, "SRAVI can be deployed on commodity smartphones and tablets, that can be used by multiple patients. Alternative technologies, such as ‘eye-gaze’ systems, require bespoke hardware and are generally much more expensive."

Shondipon Laha, Consultant in Critical Care and Anaesthesia, Lancashire Teaching Hospital, explained further, "This project will address a government priority to implement new digital solutions in the NHS. SRAVI will deliver improved patient-carer communications for patients with tracheostomies, thus reducing rehabilitation times in expensive ICU settings."

The project will run for 9 months and will include an evaluation phase, carried out in hospital critical care environments in Lancashire and Belfast. It has been funded by UK Research and Innovation - a new organisation that brings together the UK Research Councils, Innovate UK and Research England. This single organisation creates the best environment for research and innovation to flourish, to ensure the UK maintains its world-leading position in research and innovation.

For further information, please visit:
https://liopa.ai

About Liopa

The company was spun out of the Centre for Secure Information Technologies (CSIT) at Queen’s University Belfast (QUB) in 2015. Since then Liopa has been onward developing and commercialising research carried out within the university into the use of Lip Movements (visemes) in Speech Recognition. The company is leveraging QUB’s renowned excellence in the area of speech, speaker and dialogue modelling to position Liopa as a leading independent provider of viseme-based VSR technology.

Most Popular Now

Is Your Marketing Effective for an NHS C…

How can you make sure you get the right message across to an NHS chief information officer, or chief nursing information officer? Replay this webinar with Professor Natasha Phillips, former...

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

AI can Predict Study Results Better than…

Large language models, a type of AI that analyses text, can predict the results of proposed neuroscience studies more accurately than human experts, finds a new study led by UCL...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...